
German hydrogen group Thyssenkrupp Nucera has slightly raised its EBIT outlook for the 2024-25 financial year, now expecting earnings between -€7 million and €7 million, an improvement from the previous -€30 million to €5 million range. The company also specified its sales forecast to between €850 million and €920 million, alongside €63 million in Q3 incoming orders. This revised guidance signals a more positive financial trajectory for the hydrogen technology provider.
Thyssenkrupp Nucera (NCH2.DE) has issued a positive revision to its financial guidance for the 2024-25 fiscal year, signaling improved operational control and a clearer path towards profitability. The company significantly narrowed its expected earnings before interest and taxes (EBIT) to a range of –€7 million to +€7 million, a substantial improvement from the previous forecast of –€30 million to +€5 million. This revision effectively raises the midpoint of its earnings outlook from a loss of €12.5 million to a break-even position, suggesting better-than-anticipated cost management or margin performance. Concurrently, the firm specified its sales outlook to between €850 million and €920 million and reported €63 million in new orders for the third quarter. While the order intake figure lacks historical context, the updated guidance, particularly on the profit front, indicates a more stable financial trajectory for the German hydrogen group.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment